The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT): Randomized parallel clinical superiority trial

BACKGROUND: We compared the health‐related quality of life (HRQOL) in patients undergoing trimodality therapy for resectable stage I‐III esophageal cancer. METHODS: A total of 96 patients were randomized to standard neoadjuvant cisplatin and 5‐fluorouracil chemotherapy plus radiotherapy (neoadjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Malthaner, Richard A., Yu, Edward, Sanatani, Michael, Lewis, Debra, Warner, Andrew, Dar, A. Rashid, Yaremko, Brian P., Bierer, Joel, Palma, David A., Fortin, Dalilah, Inculet, Richard I., Fréchette, Eric, Raphael, Jacques, Gaede, Stewart, Kuruvilla, Sara, Younus, Jawaid, Vincent, Mark D., Rodrigues, George B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250846/
https://www.ncbi.nlm.nih.gov/pubmed/35611396
http://dx.doi.org/10.1111/1759-7714.14433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250846/
https://www.ncbi.nlm.nih.gov/pubmed/35611396
http://dx.doi.org/10.1111/1759-7714.14433

Ejemplares similares